NASBY LIMONTAS: Open Payments
NPI 1770176836 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$820 in 43 payments from 14 companies in 2025. Trend: 2023 $452 · 2024 $1,012 · 2025 $820
Food & beverage: $820
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $178 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $124 |
| Astellas Pharma US Inc | 4 | $98 |
| Exact Sciences Corporation | 6 | $90 |
| SANOFI-AVENTIS U.S. LLC | 4 | $72 |
| Lilly USA, LLC | 4 | $68 |
| ABBVIE INC. | 3 | $54 |
| Dynavax Technologies Corporation | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Amgen Inc. | 1 | $22 |
Products named: Veozah, Cologuard Collection Kit, TZIELD, JARDIANCE, Wegovy, Ozempic, MOUNJARO, QULIPTA.
Industry payments across GA — which companies pay providers there.
